Study findings support revising current renal cell carcinoma staging to enhance treatment decision-making. Subclassifying T1 stage renal cell carcinoma (RCC) into 3 subgroups enhances risk ...
The University of Kentucky Markey Cancer Center's Graham Warren, M.D., Ph.D., and international collaborators have led a groundbreaking study that could change the way lung cancer is diagnosed and ...
Of 15 IRs, 47% were locoregional only. Among T1ab patients not treated with adjuvant trastuzumab or chemotherapy (n = 171), the 5-year invasive DRFI was 98.2% (95% CI, 94.5% to 99.4%); it was 99.0% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results